Insiders · Profile

Bachrodt Amy

SVP, Finance at Maze Therapeutics. Filing since 29 Dec 2025. CIK 0002050422

Company

Date

Role

Action

Shares

Amount

Of holding

MAZE Maze Therapeutics, Inc.

1 Apr 2026

SVP, Finance

Sold on a plan

2,500

$73.61K

16.2%

MAZE Maze Therapeutics, Inc.

2 Mar 2026

SVP, Finance

Sold on a plan

5,000

$226.01K

27.8%

MAZE Maze Therapeutics, Inc.

2 Feb 2026

SVP, Finance

Sold on a plan

5,000

$230.22K

27.8%

MAZE Maze Therapeutics, Inc.

22 Jan 2026

SVP, Finance

Sold on a plan

5,000

$227.61K

27.8%

MAZE Maze Therapeutics, Inc.

2 Jan 2026

SVP, Finance

Sold on a plan

5,000

$195.75K

27.8%

MAZE Maze Therapeutics, Inc.

30 Dec 2025

SVP, Finance

Sold on a plan

5,000

$200.41K

27.8%

MAZE Maze Therapeutics, Inc.

29 Dec 2025

SVP, Finance

Sold on a plan

10,000

$405.77K

43.5%

7 decisions on file.